News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,729 Results
Type
Article (31958)
Company Profile (11)
Press Release (139760)
Multimedia
Podcasts (5)
Webinars (9)
Section
Business (52121)
Career Advice (364)
Deals (3241)
Drug Delivery (8)
Drug Development (23841)
Employer Resources (32)
FDA (3345)
Job Trends (3183)
News (80673)
Policy (4361)
Tag
Academia (2401)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (20)
Alliances (10896)
ALS (29)
Alzheimer's disease (524)
Antibody-drug conjugate (ADC) (22)
Approvals (3372)
Artificial intelligence (55)
Autoimmune disease (1)
Automation (4)
Bankruptcy (33)
Best Places to Work (2656)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (25)
Brain cancer (9)
Breast cancer (87)
Cancer (641)
Cardiovascular disease (41)
Career advice (337)
Career pathing (9)
CAR-T (44)
Cell therapy (114)
Cervical cancer (6)
Clinical research (18567)
Collaboration (170)
Company closure (1)
Compensation (10)
Complete response letters (1)
COVID-19 (1176)
CRISPR (13)
C-suite (161)
Cystic fibrosis (23)
Data (795)
Decentralized trials (1)
Denatured (4)
Depression (6)
Diabetes (57)
Diagnostics (1652)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (20)
Earnings (6365)
Editorial (7)
Employer branding (2)
Employer resources (29)
Events (17657)
Executive appointments (469)
FDA (3606)
Frontotemporal dementia (4)
Funding (204)
Gene editing (35)
Generative AI (3)
Gene therapy (78)
GLP-1 (128)
Government (973)
Guidances (8)
Healthcare (5032)
Huntington's disease (2)
IgA nephropathy (8)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1212)
Inflammatory bowel disease (43)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (19)
Interviews (41)
IPO (1463)
IRA (6)
Job creations (591)
Job search strategy (315)
Kidney cancer (5)
Labor market (7)
Layoffs (37)
Leadership (2)
Legal (817)
Liver cancer (21)
Lung cancer (83)
Lymphoma (48)
Machine learning (2)
Management (9)
Manufacturing (39)
MASH (28)
Medical device (3033)
Medtech (3034)
Mergers & acquisitions (1814)
Metabolic disorders (126)
Multiple sclerosis (19)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (1)
Neuroscience (653)
NextGen: Class of 2025 (1795)
Non-profit (1699)
Now hiring (4)
Obesity (40)
Opinion (30)
Ovarian cancer (33)
Pain (19)
Pancreatic cancer (30)
Parkinson's disease (39)
Partnered (4)
Patents (41)
Patient recruitment (35)
Peanut (12)
People (32379)
Phase I (5900)
Phase II (8503)
Phase III (5652)
Pipeline (212)
Policy (25)
Postmarket research (960)
Preclinical (3068)
Press Release (25)
Prostate cancer (28)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (91)
Real estate (1274)
Recruiting (15)
Regulatory (3022)
Reports (3)
Research institute (1349)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (9)
Series A (30)
Series B (19)
Sickle cell disease (16)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1103)
Stomach cancer (1)
Tariffs (3)
The Weekly (1)
Vaccines (208)
Venture capitalists (2)
Weight loss (22)
Women's health (7)
Worklife (2)
Date
Today (17)
Last 7 days (165)
Last 30 days (626)
Last 365 days (6944)
2025 (2411)
2024 (7451)
2023 (9218)
2022 (11491)
2021 (13233)
2020 (12771)
2019 (12184)
2018 (9029)
2017 (8716)
2016 (8896)
2015 (10228)
2014 (7813)
2013 (7605)
2012 (7575)
2011 (7593)
2010 (6795)
Location
Africa (262)
Alabama (11)
Alaska (3)
Arizona (38)
Arkansas (6)
Asia (10422)
Australia (2611)
California (1389)
Canada (428)
China (105)
Colorado (60)
Connecticut (72)
Delaware (30)
Europe (27616)
Florida (162)
Georgia (50)
Idaho (12)
Illinois (126)
India (3)
Indiana (62)
Iowa (2)
Japan (49)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (156)
Massachusetts (898)
Michigan (39)
Minnesota (70)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (14)
New Hampshire (8)
New Jersey (392)
New Mexico (8)
New York (403)
North Carolina (267)
North Dakota (2)
Northern California (671)
Ohio (69)
Oklahoma (5)
Oregon (9)
Pennsylvania (274)
Puerto Rico (1)
Rhode Island (12)
South America (288)
South Carolina (3)
Southern California (508)
Tennessee (25)
Texas (214)
United States (5030)
Utah (45)
Virginia (35)
Washington D.C. (18)
Washington State (139)
West Virginia (1)
Wisconsin (11)
171,729 Results for "purdue university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation
May 12, 2025
·
5 min read
Bankruptcy
Purdue Files for Bankruptcy Anew to Support $7.4B+ Opioid Settlement
The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the Sackler family too much protection.
March 20, 2025
·
2 min read
·
Tristan Manalac
Legal
Purdue Pharma, Sacklers Settle Opioid Lawsuits For $7.4B
The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid crisis, according to the office of Massachusetts Attorney General Andrea Joy Campbell.
January 24, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Policy
SCOTUS Blocks $6B Purdue Pharma Bankruptcy Settlement
The Supreme Court of the United States has granted the Department of Justice’s motion for a stay regarding Purdue’s bankruptcy case and is set to assess the legality of the settlement in December.
August 11, 2023
·
2 min read
·
Tristan Manalac
BioMidwest
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.
September 15, 2023
·
5 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
Australian biotech company Ferronova announced today that it has signed a licensing agreement with the Purdue Research Foundation (PRF) for the application of PRF’s patented Fibroblast Activation Protein (FAP) inhibitor in magnetic resonance imaging (MRI) and MRI-guided therapies.
August 23, 2023
·
5 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.
April 8, 2024
·
6 min read
1 of 17,173
Next
